Antibody capable of binding specifically to Abeta-oligomer, and use thereof

Details for Australian Patent Application No. 2009211635 (hide)

Owner Immunas Pharma, Inc. National Center for Geriatrics and Gerontology

Inventors Shibata, Masao; Matsubara, Etsuro; Yokoseki, Tatsuki

Agent Davies Collison Cave

Pub. Number AU-A-2009211635

PCT Pub. Number WO2009/099176

Priority 61/085,545 01.08.08 US; 2008-028386 08.02.08 JP; 2008-201058 04.08.08 JP

Filing date 6 February 2009

Wipo publication date 13 August 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

26 August 2010 PCT application entered the National Phase

  PCT publication WO2009/099176 Priority application(s): WO2009/099176

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211658-Hydroisomerization catalyst, process for producing the same, method of dewaxing hydrocarbon oil, and process for producing lube base oil

2009211623-Hydrophilic polysiloxane monomer, and production method and application thereof